Insights from 2025 ASCO® GU Annual Meeting

 

Summaries & Highlights
06:28

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Summary: Preferred Treatment Regimens for Rare GU Malignancies

FEATURING Nicholas Simon
  • 4 views
  • April 12, 2025
08:20

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Summary: SOLAR & SATURN Clinical Trials - Comparing the Progression of De Novo vs. Recurrent PSMA-Defined Oligo-M1 Prostate Cancer Following Systemic Therapy & Tumor-Directed Therapy

FEATURING Amar Kishan
  • 6 views
  • April 12, 2025
08:49

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Summary: Immunogenomic Determinants of Exceptional Response to ICI in RCC - Data From CheckMate 214 and JAVELIN Renal 101

FEATURING Renee Maria Saliby
  • 31 views
  • March 19, 2025
20:17

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Summary: The Future of Biomarkers in RCC

FEATURING Samra Turajlic
  • 37 views
  • March 10, 2025
20:24

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Summary: Striving Toward New Frontiers in Clear Cell Kidney Cancer - Insights From Key Trials

FEATURING Tian Zhang
  • 114 views
  • March 4, 2025
05:43

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Summary: Advances in Metastatic Prostate Cancer Treatment - AI, Genomics, Radioligand Therapy, and Drug Comparisons

FEATURING Pedro Barata
  • 132 views
  • March 4, 2025
17:38

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Summary: The Changing World of NMIBC

FEATURING Bogdana Schmidt
  • 67 views
  • February 26, 2025
19:15

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Summary: Biomarkers in RCC - Current State and Future Potential

FEATURING Simpa Salami
  • 145 views
  • February 26, 2025
18:14

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Summary: The Promise of ADCs in Combination Therapies for Advanced/Metastatic Urothelial Cancer

FEATURING Terence Friedlander
  • 161 views
  • February 24, 2025
  • 1
09:00

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Insights: Retreatment With EV/Pembro or ICI After Prior ICI in Advanced Urothelial Cancer - UNITE & KEYNOTE Analysis

FEATURING Vadim Koshkin
  • 154 views
  • February 24, 2025
  • 1
09:45

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Summary: Adjuvant Therapy in RCC - A Practical Guide

FEATURING Laurence Albiges
  • 79 views
  • February 24, 2025
  • 2
09:01

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Summary: Perioperative Strategies in MIBC - Key Trial Insights Including CheckMate 274, NIAGARA, and RETAIN-2

FEATURING Elizabeth R. Plimack
  • 247 views
  • February 20, 2025